Puma Biotechnology, Inc (PBYI) insider trading

Every open-market stock purchase and sale by Puma Biotechnology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Alessandra Cesano (Director) and 1 other sold $612K in the last 90 days.
  • Last insider buy: Richard Paul Bryce (VP), $2.3K, 12 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $2.1M (14 sales). Last close $11.26 on Oct 22, 2026.

Recent PBYI insider trades

DateInsiderTradeValue
Sep 14, 2026Alessandra Cesano (Director)Sold$567K
Sep 14, 2026Alessandra Cesano (Director)Bought (not open market)$147K
Sep 14, 2026Troy Edward Wilson (Director)Sold$45.5K
Sep 14, 2026Alessandra Cesano (Director)Bought (not open market)—
Jul 6, 2026Alan H Auerbach (CEO)Sold$364K
Jul 6, 2026Maximo F Nougues (CFO)Sold$77.6K
Jul 6, 2026Douglas M Hunt (Officer)Sold$69.9K
Jun 12, 2026Adrian Senderowicz (Director)Sold$194K
Jun 12, 2026Jay M Moyes (Director)Sold$159K
Jun 12, 2026Allison Dorval (Director)Sold$83.6K
Jun 12, 2026Troy Edward Wilson (Director)Sold$77.7K
Jun 12, 2026Brian M Stuglik (Director)Sold$58.3K
Jun 11, 2026Adrian Senderowicz (Director)Bought (not open market)—
Jun 11, 2026Alessandra Cesano (Director)Bought (not open market)—
Jun 11, 2026Allison Dorval (Director)Bought (not open market)—
Jun 11, 2026Jay M Moyes (Director)Bought (not open market)—
Jun 11, 2026Michael Patrick Miller (Director)Bought (not open market)—
Jun 11, 2026Brian M Stuglik (Director)Bought (not open market)—
Jun 11, 2026Troy Edward Wilson (Director)Bought (not open market)—
Feb 18, 2026Douglas M Hunt (Officer)Bought (not open market)—
Feb 18, 2026Douglas M Hunt (Officer)Bought (not open market)—
Feb 18, 2026Maximo F Nougues (CFO)Bought (not open market)—
Feb 18, 2026Maximo F Nougues (CFO)Bought (not open market)—
Feb 18, 2026Alan H Auerbach (CEO)Bought (not open market)—
Feb 18, 2026Alan H Auerbach (CEO)Bought (not open market)—

Who's trading PBYI

Get free alerts when an insider at Puma Biotechnology, Inc files a new trade →